US › Healthcare

Neuroone Medical Technologies Corp (NMTC)

US · Healthcare · Medical Devices

$1.69-0.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.4M
Revenue YoY
+72.5%
Net profit
$-2.1M
Profit YoY
+8.1%
EPS
$-0.25
EPS estimate
$-0.23
Net margin
-87.2%

EPS came in at -0.25 against a street estimate of -0.23 — a miss of 8.4%.

Key statistics

Market cap
$14.7M
Forward P/E
0.0
P/B
2.75
Book value
$0.62
EPS (TTM)
$-0.90
52-week high
$6.96
52-week low
$1.61
50-day MA
$2.96
200-day MA
$4.18
Beta
0.53

Analyst view

Analysts rate Neuroone Medical Technologies Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $9.93.

Shareholding

Insiders
26.40%
Institutions
22.64%

Largest institutional holders

FundStake
Bleichroeder LP7.66%
Bard Associates Inc3.52%
Vanguard Capital Management, LLC2.68%
Renaissance Technologies Corp1.26%
Geode Capital Management, LLC1.18%
Sio Capital Management, LLC0.95%
Vanguard Fiduciary Trust Co0.56%
Essex Investment Management Company, LLC0.50%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Neuroone Medical Technologies Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.